ATE345332T1 - 2-(n-cyanimino)thiazolidin-4-on derivate - Google Patents

2-(n-cyanimino)thiazolidin-4-on derivate

Info

Publication number
ATE345332T1
ATE345332T1 AT99974189T AT99974189T ATE345332T1 AT E345332 T1 ATE345332 T1 AT E345332T1 AT 99974189 T AT99974189 T AT 99974189T AT 99974189 T AT99974189 T AT 99974189T AT E345332 T1 ATE345332 T1 AT E345332T1
Authority
AT
Austria
Prior art keywords
group
alkyl group
atom
hydrogen atom
branched
Prior art date
Application number
AT99974189T
Other languages
English (en)
Inventor
Fumio Yoneda
Hironori Ohde
Mayumi Watanabe
Takashi Ando
Takuya Yasusa
Yuko Uegaki
Original Assignee
Fujimoto Brothers Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujimoto Brothers Co Ltd filed Critical Fujimoto Brothers Co Ltd
Application granted granted Critical
Publication of ATE345332T1 publication Critical patent/ATE345332T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/54Nitrogen and either oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/64Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/68Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/70Sulfur atoms
    • C07D277/74Sulfur atoms substituted by carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Cosmetics (AREA)
AT99974189T 1999-11-12 1999-11-12 2-(n-cyanimino)thiazolidin-4-on derivate ATE345332T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP1999/006352 WO2001036402A1 (fr) 1998-07-14 1999-11-12 Nouveaux derives de 2-(n-cyano-imino)thiazolidin-4-one

Publications (1)

Publication Number Publication Date
ATE345332T1 true ATE345332T1 (de) 2006-12-15

Family

ID=14237278

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99974189T ATE345332T1 (de) 1999-11-12 1999-11-12 2-(n-cyanimino)thiazolidin-4-on derivate

Country Status (15)

Country Link
US (1) US6380229B1 (de)
EP (1) EP1142885B1 (de)
JP (1) JP4285723B2 (de)
KR (1) KR100608416B1 (de)
CN (1) CN1159305C (de)
AT (1) ATE345332T1 (de)
AU (1) AU767923C (de)
CA (1) CA2355243C (de)
DE (1) DE69934027T2 (de)
DK (1) DK1142885T3 (de)
ES (1) ES2276547T3 (de)
HK (1) HK1041691B (de)
IL (1) IL144229A (de)
PT (1) PT1142885E (de)
WO (1) WO2001036402A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2248107T3 (es) 1999-08-31 2006-03-16 Incyte San Diego Incorporated Benciliden-tiazolidindionas y analogos y su utilizacion en el tratamiento de la diabetes.
JP2001199888A (ja) 2000-01-24 2001-07-24 Fujimoto Brothers:Kk 糖尿病治療剤
AU2002252227A1 (en) 2001-03-07 2002-09-24 Maxia Pharmaceuticals, Inc. Heterocyclic derivatives for the treatment of cancer and other proliferative diseases
WO2002072543A2 (en) 2001-03-08 2002-09-19 Maxia Pharmaceuticals, Inc. Rxr activating molecules
EP1392661A1 (de) 2001-05-16 2004-03-03 Boehringer Ingelheim Pharmaceuticals Inc. Diarylharnstoffderivate, die sich als entzündungshemmende mittel eignen
AU2002352706A1 (en) 2001-11-15 2003-06-10 Maxia Pharmaceuticals, Inc. N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders, cancer, and other diseases
TW200304375A (en) * 2001-12-06 2003-10-01 Maxia Pharmaceuticals Inc 2-Substituted thiazolidinone and oxazolidinone derivatives for the inhibition of phosphatases and the treatment of cancer
US7196108B2 (en) 2002-03-08 2007-03-27 Incyte San Diego Inc. Bicyclic heterocycles for the treatment of diabetes and other diseases
US7102000B2 (en) 2002-03-08 2006-09-05 Incyte San Diego Inc. Heterocyclic amide derivatives for the treatment of diabetes and other diseases
DE602004029493D1 (de) 2003-11-21 2010-11-18 Actelion Pharmaceuticals Ltd 5-(benz- (z) -yliden) -thiazolidin-4-onderivate als das immunsystem unterdrückende mittel
USRE43833E1 (en) 2003-11-21 2012-11-27 Actelion Pharmaceuticals Ltd. Thiazolidin-4-one derivatives
US8912340B2 (en) 2006-11-23 2014-12-16 Actelion Pharmaceuticals Ltd. Process for the preparation of 2-imino-thiazolidin-4-one derivatives
DK2094676T3 (da) * 2006-11-23 2013-06-10 Actelion Pharmaceuticals Ltd Ny fremgangsmåde til fremstillingen af 2-iminothiazolidin-4-on-derivater
US7858666B2 (en) 2007-06-08 2010-12-28 Mannkind Corporation IRE-1α inhibitors
PT2885266T (pt) 2012-08-17 2020-05-29 Actelion Pharmaceuticals Ltd Processo para a preparação de (2z,5z)-5-(3-cloro-4-((r)-2,3-di-hidropropoxi)benzilideno)-2-(propilimino)-3-(o-tolil)tiazolidin-4-ona e intermediário utilizado no referido processo

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07165371A (ja) 1993-10-06 1995-06-27 Japan Tobacco Inc テープ巻き付け方法および装置
JPH0892249A (ja) 1994-07-20 1996-04-09 Sankyo Co Ltd スルホンアミド誘導体
JP3871354B2 (ja) 1994-07-29 2007-01-24 株式会社フジモト・コーポレーション 新規な2−(n−シアノイミノ)チアゾリジン−4−オン誘導体
JPH08157461A (ja) 1994-12-07 1996-06-18 Sankyo Co Ltd スルホン誘導体
JPH09165371A (ja) 1995-10-09 1997-06-24 Sankyo Co Ltd 複素環化合物を含有する医薬
DE69625795T2 (de) * 1996-04-09 2003-08-14 Reddys Lab Ltd Dr Thiazolidinedionderivate mit antidiabetischen, hypolipidämischen und antihypertensiven Eigenschaften, Verfahren zu deren Herstellung und pharmazeutischen Zusammenstellungen, die sie enthalten
JP2000026438A (ja) * 1998-07-14 2000-01-25 Fujimoto Brothers:Kk 新規な2−(n−シアノイミノ)チアゾリジン−4− オン誘導体

Also Published As

Publication number Publication date
JP4285723B2 (ja) 2009-06-24
US6380229B1 (en) 2002-04-30
CA2355243A1 (en) 2001-05-25
CN1159305C (zh) 2004-07-28
WO2001036402A1 (fr) 2001-05-25
EP1142885A4 (de) 2003-01-29
CA2355243C (en) 2009-01-27
ES2276547T3 (es) 2007-06-16
IL144229A0 (en) 2002-05-23
DK1142885T3 (da) 2007-02-26
KR20010108089A (ko) 2001-12-07
PT1142885E (pt) 2007-02-28
KR100608416B1 (ko) 2006-08-02
EP1142885A1 (de) 2001-10-10
DE69934027D1 (de) 2006-12-28
CN1333762A (zh) 2002-01-30
DE69934027T2 (de) 2007-06-21
IL144229A (en) 2006-10-05
AU1180100A (en) 2001-05-30
EP1142885B1 (de) 2006-11-15
HK1041691A1 (en) 2002-07-19
AU767923C (en) 2005-03-24
AU767923B2 (en) 2003-11-27
HK1041691B (zh) 2004-12-24

Similar Documents

Publication Publication Date Title
ATE345332T1 (de) 2-(n-cyanimino)thiazolidin-4-on derivate
NO20012617D0 (no) Kinolin- og kinzolinderivater
EP0749974A4 (de) Phosphorsäurediester-derivate
DE69624143T2 (de) Phosphonsaurediester-derivate
DE69613710T2 (de) Benzoxazepinverbindungen, ihre herstellung und verwendung als lipidsenker
DK0918776T3 (da) Totalsyntese af antitumor acylfulvener
DK0390654T3 (da) Aminobenzensulfonsyrederivater
DK0594263T3 (da) Mellemprodukter til fremstilling af thioalkylthio-cephalosporinderivater
IL145336A0 (en) Therapeutic agents for diabetes
ES2089041T5 (es) Compuestos de piridinasulfonamida sustituida, composiciones herbicidas que los contienen, y procedimiento para su preparacion.
WO2001044207A3 (fr) Nouveaux derives amino substitues ramifies du 3-amino-1-phenyl-1h[1,2 4]triazole, procedes pour leur preparation et compositions pharmaceutiques les contenant
DE69612967T2 (de) Optisch aktive thiazolidinonderivate
DE69915471D1 (de) Analoga von distamycin-zimtsäurederivaten, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel
PT1284267E (pt) Compostos de triazole possuindo uma ligacao amida
FI883584A (fi) Foerfarande foer framstaellning av 2'-deoxi-5-fluorouridins derivat.
WO2001044197A3 (fr) Derives de 2-phenyl-quinoleine et leur utilisation en tant qu'agent contractant des muscles lisses
DE69626624T2 (de) Medikamente gegen trhombocytopenie

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1142885

Country of ref document: EP